Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue [NA]
A pivotal study evaluating the NanoKnife System for the ablation of prostate tissue has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression [NA]
This is a completed Johns Hopkins–sponsored clinical trial named EMPOWER Men that investigates weight reduction as a strategy to slow progre…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer [NA]
A completed clinical trial evaluated biomarkers associated with sulforaphane from broccoli sprout extract in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer [Phase 3]
A Phase 3 clinical trial evaluating antibiotic prophylaxis during HDR brachytherapy for prostate cancer has been terminated.
-
FDA approval · 2025-02-11FDA Approved: CAMCEVI — Supplemental Application (Accord BioPharma, Inc.)
FDA approved a supplemental application for CAMCEVI (leuprolide) from Accord BioPharma, Inc., expanding regulatory approval for this long-ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females [Phase 1]
A Phase 1 pharmacokinetic study assessing how castration from androgen deprivation therapy affects zolpidem PK after a single dose in men wi…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
A clinical trial evaluating the PARP inhibitor olaparib for castration-resistant prostate cancer, including patients with BRCA mutations; cu…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer
An ongoing clinical trial (NCT06820333) evaluates [18F] PSMA-1007 PET imaging for primary staging of prostate cancer. The study is currently…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer
A recruiting clinical study evaluating whether adding apparent diffusion coefficient measurements to biparametric MRI improves the diagnosti…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II trial update for VB15010 tablets in advanced solid tumors; the study is currently recruiting across multiple cancer types.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
A completed clinical trial study reports on a diagnostic prediction model for detecting prostate cancer in patients with a PI-RADS score of …
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
This clinical trial compares 5.0T and 3.0T biparametric MRI for diagnosing prostate cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy [NA]
A clinical trial update indicating ongoing recruitment for MR-guided radiotherapy targeting subclinical metastatic disease in prostate cance…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer [NA]
This entry updates a clinical trial evaluating a low-fat diet and fish oil in men with prostate cancer on active surveillance; the study is …
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era [NA]
A clinical trial update announcing recruitment for salvage MR-guided high-dose-rate brachytherapy to treat prostate bed recurrence after pri…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer [Phase 2]
A Phase 2 trial is evaluating 177Lu-PSMA-617 as a systemic adjuvant treatment for high and very high risk prostate cancer; the study is curr…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin) [NA]
Clinical trial update describing advanced imaging to guide radiotherapy planning for low- to intermediate-risk prostate cancer (Margin); the…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms [Phase 2]
Phase 2 clinical trial update assessing novel treatment algorithms for adding local tumour treatments in metastatic prostate cancer; the stu…
-
CLINICAL_TRIALS other · 2025-02-07Clinical Trial Update: Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Clinical trial update on a Phase 1/Phase 2 study combining Radium-223 with Lutetium-177 PSMA-I&T for metastatic castration-resistant prostat…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. [NA]
Clinical trial results assess late toxicity after intensity-modulated radiotherapy for prostate cancer, comparing two image-guided strategie…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Dual-Tracer Theranostic PET [NA]
Clinical trial update on dual-tracer theranostic PET imaging for neuroendocrine tumors and prostate cancer; results have been posted.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating enzalutamide in first-line androgen deprivation therapy for metastatic prostate cancer; the study status i…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI
This clinical trial update notes that UC San Diego is recruiting to evaluate prostate cancer using Restriction Spectrum Imaging (RSI) MRI.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Low Pressure Pneumoperitoneum and Deep Neuromuscular Block vs. Standard During RARP to Improve Quality of Recovery; a Randomized Controlled Study. [NA]
This randomized controlled trial evaluated low-pressure pneumoperitoneum with deep neuromuscular blockade vs standard technique during robot…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer [NA]
Completed single-center, single-arm study evaluating the safety and efficacy of the radiopharmaceutical 177Lu-LNC1011 in PSMA PET-positive m…